Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of vasopressin spray in China. Welcome to wholesale bulk high quality vasopressin spray for sale here from our factory. Good service and reasonable price are available.
As an indispensable endogenous peptide active substance in the body's steady-state regulation system, vasopressin spray, with its unique molecular structure and precise targeting properties, plays an irreplaceable and critical role in the three core areas of vascular tension regulation, coagulation function regulation, and critical state resuscitation intervention, which are difficult to be replaced by other active substances. Its related regulatory effects are not single and fixed, but exhibit distinct scene specificity.
Under different physiological rhythms or pathological stress environments, it can present differentiated action tendencies and intensities according to the actual needs of the body, providing solid support and guarantee for the body to cope with various abnormal physiological states and resist pathological damage. Compared to other active substances involved in steady-state regulation, it has more precise and synergistic effects, and can adapt to the needs of the body in different scenarios through a multi-path and multi-target regulation mode.
Our Products
Vasopressin COA
The dynamic regulatory effect of vascular resistance and arterial blood pressure
Vasopressin spray has a concentration dependent regulation of vascular resistance and arterial plasma pressure, exhibiting distinct dominant effects at different concentration thresholds. Under stress conditions, it can achieve steady-state maintenance of circulatory perfusion through specific release. Its specific functional logic can be developed from the following dimensions:
The differentiation characteristics of concentration dependent effects. Under normal physiological rhythms, the secretion of it is at the basal concentration threshold, and its core efficacy is focused on regulating water metabolism, with vascular related effects in a secondary position. It can only have a weak impact on vascular tension and cannot dominate the regulation of arterial plasma pressure. In this state, its focus of action always leans towards maintaining the steady state of water reabsorption, and the effects related to vascular regulation are significantly weakened.i.
The dominant mechanism of pressure rise under high concentration conditions. When the secretion of it significantly increases and exceeds the physiological concentration threshold, its center of action shifts significantly, and vascular regulatory effects become dominant. This substance can induce the contraction response of vascular smooth muscle by targeting specific receptors on the peripheral plasma vessel wall, thereby enhancing the resistance level of peripheral plasma vessels and promoting a positive increase in arterial plasma pressure. This pressor effect has strong specificity and can quickly respond to the needs of plasma pressure regulation in the body.
The perfusion maintenance function under stress. When the body encounters critical stress scenarios such as shock, this will be significantly and explosively released. Its core purpose is to improve the imbalance of circulation and perfusion by enhancing vasoconstriction and increasing peripheral vascular resistance. This release can prioritize the plasma supply to core organs such as the heart and brain, reduce tissue ischemia and hypoxia damage caused by insufficient perfusion, provide key support for the body to cope with shock state and maintain basic vital signs, and is an important component of the body's stress compensation mechanism.
The supporting information source for the above part is:
Optimal Vasoprassin Initiation in Septic Shock: The OVISS Reinforcement Learning Study, JAMA, 2025 May 20; 333(19):1688-1698
Vasoprassin drives aberrant myeloid differentiation of hematopoietic stem cells, contributing to depression in mice, Cell Stem Cell, 2024 Dec 5; 31(12):1794-1812.e10
Targeted regulatory effects on bleeding and coagulation
In the physiological regulation system of bleeding and coagulation, the related efficacy of this med is mainly achieved through its synthetic analogue DDAVP, with a focus on intervening in hemophilia related bleeding. Through specific molecular mediation, it enhances the body's coagulation response ability. Its specific action details can be divided into the following points:
Molecular mediated mechanism of DDAVP
As an artificially synthesized analog of it, DDAVP has a molecular structure highly compatible with endogenous vasopressin spray. It can activate intracellular signaling pathways by targeting specific receptors on the surface of endothelial cells, thereby inducing the release of vascular hemophilia factor stored in endothelial cells into the plasma, achieving a rapid increase in the concentration of this factor.
The coagulation synergistic effect of von Willebrand factor.
The released von Willebrand factor can participate in the body's coagulation process through multiple pathways
On the one hand, it can enhance the adhesion and aggregation ability of platelets, promote platelet recruitment at the site of vascular injury, and form preliminary hemostatic plugs; On the other hand, it can serve as a carrier to protect coagulation related factors from rapid clearance, prolong their action time in plasma circulation, enhance the body's coagulation response, and reduce bleeding tendency.
The intervention value of hemophilia related bleeding
In response to various bleeding scenarios caused by hemophilia, DDAVP can rapidly increase the concentration of hemophilia factor in the body through the above mechanism, compensate for the congenital or acquired deficiency of this factor in the patient's body, correct bleeding abnormalities, and alleviate bleeding symptoms. This intervention method has the characteristics of strong targeting and rapid effectiveness, and can be widely used for acute bleeding management and perioperative hemostasis intervention in patients with hemophilia.
The supporting information source for the above part is:
Effect of Vasoprassin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest, JAMA, 2021 Oct 26; 326(16):1586-1594
The auxiliary pressor effect in cardiopulmonary resuscitation
In the intervention of cardiac and pulmonary resuscitation for refractory cardiac arrest, vasopressin, as an important auxiliary intervention substance, has the core efficacy of assisting pressure rise through vasoconstriction effect, improving systemic perfusion, and providing support for the successful resuscitation of cardiac arrest. Its specific mechanism of action and application characteristics can be explored from the following aspects:
Intervention needs for refractory cardiac arrest. Refractory cardiac arrest often manifests as the inability of conventional resuscitation methods to effectively restore spontaneous rhythm and arterial plasma pressure. At this time, the body's circulatory perfusion is severely insufficient, and core organs such as the heart and brain are facing severe ischemia and hypoxia. It is urgent to use vasoactive substances to increase vascular resistance and improve perfusion, creating favorable conditions for cardiac arrest.
The core pathway of auxiliary boosting. Vasopressin spray can activate specific receptors on the smooth muscle surface of plasma vessels, induce the contraction of peripheral plasma vessels throughout the body, significantly increase peripheral vascular resistance, and promote a positive increase in arterial plasma pressure, thereby improving the circulatory perfusion status of the body. Compared with other vasoactive substances, its pressor effect is more stable and can effectively increase vascular tone at lower doses, providing sustained support for circulation maintenance during cardiopulmonary resuscitation.
The synergistic value of recovery intervention. During the resuscitation process of refractory cardiac arrest, the auxiliary pressor effect of it can form a synergistic effect with conventional resuscitation methods such as chest compressions and artificial ventilation, by increasing vascular resistance, improving myocardial and brain tissue perfusion, enhancing the probability of successful resuscitation, reducing irreversible organ function damage caused by long-term ischemia and hypoxia, and buying valuable time for subsequent treatment of patients.
The supporting information source for the above part is:
The effect of vasopresin acetate on symptoms, bladder capacity, and sleep status in children with enuresis, International Journal of Urology, 2025, 45 (03): 143-147
This has always demonstrated irreplaceable, unique, and crucial physiological regulatory value and clinical application significance in three core scenarios: dynamic regulation of vascular resistance and arterial plasma pressure, targeted intervention of bleeding and coagulation processes, and auxiliary pressure boosting for refractory cardiac arrest and cardiopulmonary resuscitation. It does not exert its effectiveness through a single fixed mode of action, but relies on the concentration dependent differentiation law to accurately switch the center of action at different physiological or pathological concentration thresholds.
Achieving flexible regulation of vascular tension and plasma pressure, by utilizing specific molecular mediated pathways, it efficiently participates in coagulation function regulation and bleeding intervention through targeted binding of itself or its synthetic analogues; With the characteristic of scenario based efficiency, it accurately adapts to the needs of the body in critical resuscitation scenarios, providing support for the maintenance of circulatory perfusion. These pathways of action work together and organically integrate, providing a solid and reliable guarantee for maintaining physiological homeostasis, correcting pathological states, and intervening in critical illnesses.
References
Vasoprassin in septic shock: an individual patient data meta-analysis of randomised controlled trials, Intensive Care Med, 2019 Jun; 45(6):844-855
1-Desamino-8-D-arginine vasopressin as a hemostatic and plasma sparing agent in bleeding disorders, PMC, 2024
Plasma proteomics in patients with von Willebrand disease and hemophilia A highlights von Willebrand factor as main determinant of response to DDAVP treatment, PMC, 2025
Vasopressors in the Setting of Cardiac Arrest, Pharmacy & Acute Care University, 2024
Norepinephrine and Vasoprassin in Hemorrhagic Shock: A Focus on Renal Hemodynamics, Int J Mol Sci, 2023 Feb 17; 24(4):4103
Hot Tags: vasopressin spray, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale